Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277524 · ClinicalTrials.gov registry record
OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Terminated
- Registry status
- 3,032
- Enrollment target
NCT00277524: Clinical Trial study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT00277524 is a clinical trial that was terminated before completion, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 3,032 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00277524 was terminated before completion, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- TERMINATED
- Registry status
- 3,032 participants
- Enrollment target
Study Summary
The purpose of the OMNI study is to characterize therapy and diagnostic utilization in study participants implanted with study devices and to describe Implantable Cardioverter Defibrillator(ICD)therapy utilization for life threatening arrhythmias in primary and secondary prevention study participants. This study will assess therapies in Medtronic pacemaker, defibrillator, and cardiac resynchronization therapy devices. The first therapy is for reducing unnecessary pacing in pacemaker patients. The second therapy provides pacing therapy in an attempt to stop fast or life threatening ventricular arrhythmias in lieu of delivering a defibrillation shock. The third therapy is a diagnostic measurement of a patient's fluid status and provides the physician information on the patient's heart failure status. The study will also assess the time to a patient's first defibrillation shock and will verify that the shock was for a fast or life threatening ventricular rhythm.
Primary Outcome
Frequencies of implanted systems were measured among patients who were implanted with a device (IPT, ICD or CRT-D).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,032 participants |
| Start Date | 2005-08 |
| Est. Completion | 2010-11 |
Why NCT00277524 stopped before completion
NCT00277524 is an observational study that tracks outcomes without assigning an intervention. Its 3,032 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00277524 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00277524 about?
NCT00277524 is a clinical study titled "OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.". The purpose of the OMNI study is to characterize therapy and diagnostic utilization in study participants implanted with study devices and to describe Implantable Cardioverter Defibrillator(ICD)therapy utilization for life threatening arrhythmias in primary and secondary prevention study participant...
What is the current status of trial NCT00277524?
This trial is currently terminated. The enrollment target is 3,032 participants. The study started on 2005-08. Estimated completion is 2010-11.
Who is sponsoring clinical trial NCT00277524?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia